Multimodal transfer of MDR by exosomes in human osteosarcoma

International Journal of Oncology

Volumn 49, Issue 1, 2016, Pages 189-196

  Torreggiani, Elena ^a   Roncuzzi, Laura ^a   Perut, Francesca ^a   Zini, Nicoletta ^a,b   Baldini, Nicola ^a,c  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Doxorubicin; Drug resistance; Exosomes; Osteosarcoma; P glycoprotein

Indexed keywords

DOXORUBICIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; ABCB1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SENSITIVITY; EXOSOME; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MG 63 CELL LINE; MG 63DXR30 CELL LINE; MULTIDRUG RESISTANCE; OSTEOSARCOMA; OSTEOSARCOMA CELL LINE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; APOPTOSIS; BIOSYNTHESIS; CELL COMMUNICATION; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL COMMUNICATION; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EXOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OSTEOSARCOMA; P-GLYCOPROTEINS;

EID: 84978413961     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3509     Document Type: Article

References (38)

1. Théry C, Zitvogel L and Amigorena S: Exosomes: Composition, biogenesis and function. Nat Rev Immunol 2: 569-579, 2002.
2. Simons M and Raposo G: Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 21: 575-581, 2009.
3. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ and Geuze HJ: B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 1161-1172, 1996.
4. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G and Amigorena S: Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat Med 4: 594-600, 1998.
5. Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, Raposo G and Hivroz C: TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 168: 3235-3241, 2002.
6. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ and Sixma JJ: Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94: 3791-3799, 1999.
7. Fontana S, Saieva L, Taverna S and Alessandro R: Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: State of the art and new perspectives. Proteomics 13: 1581-1594, 2013.
8. De Jong OG, Van Balkom BW, Schiffelers RM, Bouten CV and Verhaar MC: Extracellular vesicles: potential roles in regenerative medicine. Front Immunol 5: 608, 2014.
9. Torreggiani E, Perut F, Roncuzzi L, Zini N, Baglìo SR and Baldini N: Exosomes: Novel effectors of human platelet lysate activity. Eur Cell Mater 28: 137-151, 2014.
10. Yang C and Robbins PD: The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011: 842849, 2011.
11. Filipazzi P, Bürdek M, Villa A, Rivoltini L and Huber V: Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 22: 342-349, 2012.
12. Gong J, Jaiswal R, Mathys JM, Combes V, Grau GE and Bebawy M: Microparticles and their emerging role in cancer multidrug resistance. Cancer Treat Rev 38: 226-234, 2012.
13. Corcoran C, Rani S, O'Brien K, O'Neill A, Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J, et al: Docetaxelresistance in prostate cancer: Evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One 7: e50999, 2012.
14. Corcoran C, Rani S and O'Driscoll L: miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression. Prostate 74: 1320-1334, 2014.
15. Lv MM, Zhu XY, Chen WX, Zhong SL, Hu Q, Ma TF, Zhang J, Chen L, Tang JH and Zhao JH: Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumour Biol 35: 10773-10779, 2014.
16. Chen WX, Liu XM, Lv MM, Chen L, Zhao JH, Zhong SL, Ji MH, Hu Q, Luo Z, Wu JZ, et al: Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One 9: e95240, 2014.
17. Heare T, Hensley MA and Dell'Orfano S: Bone tumors: Osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr 21: 365-372, 2009.
18. Baldini N, Scotlandi K, Barbanti-Bròdano G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S, Campanacci M, et al: Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med 333: 1380-1385, 1995.
19. Li S, Sun W, Wang H, Zuo D, Hua Y and Cai Z: Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal. Tumour Biol 36: 1329-1338, 2015.
20. Roncuzzi L, Pancotti F and Baldini N: Involvement of HIF-1 activation in the doxorubicin resistance of human osteosarcoma cells. Oncol Rep 32: 389-394, 2014.
21. Salerno M, Avnet S, Bonuccelli G, Hosogi S, Granchi D and Baldini N: Impairment of lysosomal activity as a therapeutic modality targeting cancer stem cells of embryonal rhabdomyosarcoma cell line RD. PLoS One 9: e110340, 2014.
22. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method. Methods 25: 402-408, 2001.
23. Su L, Mruk DD, Lui WY, Lee WM and Cheng CY: P-glycoprotein regulates blood-testis barrier dynamics via its effects on the occludin/zonula occludens 1 (ZO-1) protein complex mediated by focal adhesion kinase (FAK). Proc Natl Acad Sci USA 108: 19623-19628, 2011.
24. Mankin HJ, Hornicek FJ, Rosenberg AE, Harmon DC and Gebhardt MC: Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res 429: 286-291, 2004.
25. Bacci G, Briccoli A, Rocca M, Ferrari S, Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, et al: Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: Recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol 14: 1126-1134, 2003.
26. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002.
27. Borst P and Elferink RO: Mammalian ABC transporters in health and disease. Annu Rev Biochem 71: 537-592, 2002.
28. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE and Gottesman MM: P-glycoprotein: From genomics to mechanism. Oncogene 22: 7468-7485, 2003.
29. Baldini N, Scotlandi K, Serra M, Picci P, Bacci G, Sottili S and Campanacci M: P-glycoprotein expression in osteosarcoma: A basis for risk-adapted adjuvant chemotherapy. J Orthop Res 17: 629-632, 1999.
30. Harguindey S, Orive G, Luis Pedraz J, Paradiso A and Reshkin SJ: The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biochim Biophys Acta 1756: 1-24, 2005.
31. Shicang Y, Guijun H, Guisheng Q, Yuying L, Guoming W and Ruiling G: Efficacy of chemotherapeutic agents under hypoxic conditions in pulmonary adenocarcinoma multidrug resistant cell line. J Chemother 19: 203-211, 2007.
32. Chen KG and Sikic BI: Molecular pathways: Regulation and therapeutic implications of multidrug resistance. Clin Cancer Res 18: 1863-1869, 2012.
33. Levchenko A, Mehta BM, Niu X, Kang G, Villafania L, Way D, Polycarpe D, Sadelain M and Larson SM: Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc Natl Acad Sci USA 102: 1933-1938, 2005.
34. Zhao L, Liu W, Xiao J and Cao B: The role of exosomes and 'exosomal shuttle microRNA' in tumorigenesis and drug resistance. Cancer Lett 356B: 339-346, 2015.
35. Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann W and Howell SB: Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 4: 1595-1604, 2005.
36. Federici C, Petrucci F, Caimi S, Cesolini A, Logozzi M, Borghi M, D'Ilio S, Lugini L, Violante N, Azzarito T, et al: Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS One 9: e88193, 2014.
37. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659, 2007.
38. Ramachandran S and Palanisamy V: Horizontal transfer of RNAs: Exosomes as mediators of intercellular communication. Wiley Interdiscip Rev RNA 3: 286-293, 2012.